Related Experiment Video
Updated: Feb 12, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Targeting interleukin-22 for cancer therapy.
Anamarija Markota1, Stefan Endres1,2, Sebastian Kobold1,2
1a Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV , Klinikum der Universität München, Munich, Germany; Member of the German Center for Lung Research (DZL).
Interleukin-22 (IL-22) promotes cancer, but understanding its regulation by cancer cells via IL-1 in T cells offers new therapeutic targets for cancer immunotherapy.
Area of Science:
- Immunology
- Oncology
Background:
- Interleukin-22 (IL-22) is an IL-10 family cytokine involved in tissue repair and host defense.
- Dysregulation of the IL-22-IL-22R1 system is linked to various cancers, including lung, breast, gastric, pancreatic, and colon cancers.
- IL-22 is produced by T cells and innate lymphoid cells, with its receptor IL-22R1 expressed on non-hematopoietic cells, making the pathway a target for anti-cancer therapy.
Purpose of the Study:
- To understand IL-22 regulation within the tumor microenvironment for developing novel anti-cancer therapies.
- To elucidate the mechanism by which cancer cells promote IL-22 production by memory T cells.
Main Methods:
- Investigated the role of IL-1 in mediating cancer cell-induced IL-22 production.
- Analyzed the IL-22-IL-22R1 pathway in the context of tumor microenvironment and cancer progression.
Main Results:
- Deciphered a mechanism where cancer cells induce IL-1 to promote IL-22 production by memory T cells.
- Highlighted the IL-22-IL-22R1 pathway as a critical component in cancer development.
Conclusions:
- Understanding cancer cell-driven IL-22 regulation via IL-1 provides insights for developing targeted cancer immunotherapies.
- Targeting the IL-22 pathway holds promise for future cancer treatment strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Therapy
Group Therapy
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications

